Transthyretin (TTR)-related amyloidoses are diseases characterized by extracellular deposition of amyloid fibrils and aggregates in tissues composed of insoluble misfolded TTR that becomes toxic. Previous studies have demonstrated the ability of small compounds in preventing and reversing TTR V30M deposition in transgenic mice gastrointestinal (GI) tract as well as lowering biomarkers associated with cellular stress and apoptotic mechanisms. In the present study we aimed to study TTR V30M aggregates effect in autophagy, a cellular mechanism crucial for cell survival that has been implicated in the development of several neurodegenerative diseases. We were able to demonstrate in cell culture that TTR V30M aggregates cause a partial impairment of the autophagic machinery as shown by p62 accumulation, whereas early steps of the autophagic flux remain unaffected as shown by autophagosome number evaluation and LC3 turnover assay. Our studies performed in TTR V30M transgenic animals demonstrated that tauroursodeoxycholic acid (TUDCA) and curcumin effectively reverse p62 accumulation in the GI tract pointing to the ability of both compounds to modulate autophagy additionally to mitigate apoptosis. Overall, our in vitro and in vivo studies establish an association between TTR V30M aggregates and autophagy impairment and suggest the use of autophagy modulators as an additional and alternative therapeutic approach for the treatment of TTR V30M-related amyloidosis.
Skip Nav Destination
Article navigation
September 2016
-
Cover Image
Cover Image
Corin protein expression in human renal proximal convoluted tubules as shown by brown staining in immunohistochemistry. See pp. 1655-1664 for further details. Image kindly provided by Qingyu Wu.
Research Article|
August 08 2016
Impairment of autophagy by TTR V30M aggregates: in vivo reversal by TUDCA and curcumin
Cristina A. Teixeira;
Cristina A. Teixeira
*Instituto de Inovação e Investigação em Saúde (I3S), Universidade do Porto, Porto 4200-135, Portugal
†Unidade de Neurobiologia Molecular, IBMC–Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto 4200-135, Portugal
Search for other works by this author on:
Maria do Rosário Almeida;
Maria do Rosário Almeida
*Instituto de Inovação e Investigação em Saúde (I3S), Universidade do Porto, Porto 4200-135, Portugal
†Unidade de Neurobiologia Molecular, IBMC–Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto 4200-135, Portugal
‡Departamento de Biologia Molecular, ICBAS–Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto 4050-313, Portugal
Search for other works by this author on:
Maria João Saraiva
*Instituto de Inovação e Investigação em Saúde (I3S), Universidade do Porto, Porto 4200-135, Portugal
†Unidade de Neurobiologia Molecular, IBMC–Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto 4200-135, Portugal
Correspondence: Professor Maria João Saraiva (email mjsaraiv@ibmc.up.pt).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
February 02 2016
Revision Received:
June 30 2016
Accepted:
July 05 2016
Accepted Manuscript online:
July 06 2016
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society
2016
Clin Sci (Lond) (2016) 130 (18): 1665–1675.
Article history
Received:
February 02 2016
Revision Received:
June 30 2016
Accepted:
July 05 2016
Accepted Manuscript online:
July 06 2016
Citation
Cristina A. Teixeira, Maria do Rosário Almeida, Maria João Saraiva; Impairment of autophagy by TTR V30M aggregates: in vivo reversal by TUDCA and curcumin. Clin Sci (Lond) 1 September 2016; 130 (18): 1665–1675. doi: https://doi.org/10.1042/CS20160075
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.